| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |